IRIDEX CORP (IRIX) Stock Price, Forecast & Analysis
USA - NASDAQ:IRIX - US4626841013 - Common Stock
IRIX Key Statistics, Chart & Performance
The current stock price of IRIX is 1.17 USD. In the past month the price increased by 5.26%. In the past year, price decreased by -34.91%.
IRIX Latest News, Press Relases and Analysis
IRIX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.44 | 220.95B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.49 | 205.21B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.74 | 151.85B | ||
| SYK | STRYKER CORP | 27.58 | 138.85B | ||
| IDXX | IDEXX LABORATORIES INC | 56.53 | 57.02B | ||
| BDX | BECTON DICKINSON AND CO | 13.09 | 54.10B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.13 | 49.99B | ||
| RMD | RESMED INC | 25.51 | 36.86B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.99 | 33.52B | ||
| PODD | INSULET CORP | 71.32 | 22.94B | ||
| DXCM | DEXCOM INC | 31.25 | 22.79B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.96 | 17.56B |
Related stock screener links
About IRIX
Company Profile
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The company develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Company Info
IRIDEX CORP
1212 Terra Bella Ave
Mountain View CALIFORNIA 94043 US
CEO: David I. Bruce
Employees: 93
Phone: 16509404700
IRIDEX CORP / IRIX FAQ
Can you describe the business of IRIDEX CORP?
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The company develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
What is the current price of IRIX stock?
The current stock price of IRIX is 1.17 USD. The price increased by 6.36% in the last trading session.
Does IRIDEX CORP pay dividends?
IRIX does not pay a dividend.
How is the ChartMill rating for IRIDEX CORP?
IRIX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is IRIDEX CORP (IRIX) stock traded?
IRIX stock is listed on the Nasdaq exchange.
What is the GICS sector and industry of IRIX stock?
IRIDEX CORP (IRIX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
IRIX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to IRIX. When comparing the yearly performance of all stocks, IRIX is a bad performer in the overall market: 85.35% of all stocks are doing better.
IRIX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to IRIX. IRIX has a bad profitability rating. Also its financial health evaluation is rather negative.
IRIX Financial Highlights
Over the last trailing twelve months IRIX reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS increased by 50% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.25% | ||
| ROE | -89.9% | ||
| Debt/Equity | 0.61 |
IRIX Forecast & Estimates
For the next year, analysts expect an EPS growth of 49% and a revenue growth 5.44% for IRIX